Abstract:Infectious diseases present tremendous challenges to human progress and public health. The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) pandemic continue to pose an imminent threat to humanity. These infectious diseases highlight the importance of developing innovative strategies to study disease pathogenesis and protect human health. Although conventional in vitro cell culture and animal models are useful in facilitating the development of effective therapeutics for infectious diseases, models that can accurately reflect human physiology and human-relevant responses to pathogens are still lacking. Microfluidic organs-on-a-chip (organ chips) are engineered microfluidic cell culture devices lined with living cells, which can resemble organ-level physiology with high fidelity by rebuilding tissue–tissue interfaces, mechanical cues, fluidic flow, and the biochemical cellular microenvironment. They present a unique opportunity to bridge the gap between in vitro experimental models and in vivo human pathophysiology and are thus a promising platform for disease studies and drug testing. In this Account, we first introduce how recent progress in organ chips has enabled the recreation of complex pathophysiological features of human infections in vitro. Next, we describe the progress made by our group in adopting organ chips and other microphysiological systems for the study of infectious diseases, including SARS-CoV-2 viral infections and intrauterine bacterial infections. Respiratory symptoms dominate the clinical manifestations of many COVID-19 patients, even involving the systemic injury of many distinct organs, such as the lung, the gastrointestinal tract, and so forth. We thus particularly highlight our recent efforts to explore how lung-on-a-chip and intestine-on-a-chip might be useful in addressing the ongoing viral pandemic of COVID-19 caused by SARS-CoV-2. These organ chips offer a potential platform for studying virus–host interactions and human–relevant responses as well as accelerating the development of effective therapeutics against COVID-19. Finally, we discuss opportunities and challenges in the development of next-generation organ chips, which are urgently needed for developing effective and affordable therapies to combat infectious diseases. We hope that this Account will promote awareness about in vitro organ microphysiological systems for modeling infections and stimulate joint efforts across multiple disciplines to understand emerging and re-emerging pandemic diseases and rapidly identify innovative interventions.This article has not yet been cited by other publications.

Editorial: 3D Organoid and Organ-on-a-chip and Their Applications for Virology and Antiviral Research

Advancements in organs-on-chips technology for viral disease and anti-viral research

The Application of Organoids in the Study of Antiviral Innate Immunity

A prospects tool in virus research: Analyzing the applications of organoids in virus studies

Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges

Organoids: a New Research Model for SARS-CoV-2infection and Treatment

Organ‐on‐a‐Chip: Patient‐Specific Organoid and Organ‐on‐a‐Chip: 3D Cell‐Culture Meets 3D Printing and Numerical Simulation (adv. Biology 6/2021)

Apical-out airway organoids as a platform for studying viral infections and screening for antiviral drugs

Microfluidic Organs-on-a-Chip for Modeling Human Infectious Diseases

Disease modeling in organoid cultures: a new tool for studying viruses

Review on the Vascularization of Organoids and Organoids-on-a-Chip

Advances in Virus-Host Interaction Research Based on Microfluidic Platforms

Mapping the scientific output of organoids for animal and human modeling infectious diseases: a bibliometric assessment

Human organoid models to study SARS-CoV-2 infection

Advances in human organoids-on-chips in biomedical research

A Potential Ex Vivo Infection Model of Human Induced Pluripotent Stem Cell-3D Organoids Beyond Coronavirus Disease 2019.

Defense of COVID-19 by Human Organoids

Microfluidic Techniques for Next‐Generation Organoid Systems (adv. Mater. Interfaces 29/2022)

Organoid and microfluidics-based platforms for drug screening in COVID-19

Organ-on-a-chip: A new tool for in vitro research

Organoid-on-a-chip: Current challenges, trends, and future scope toward medicine